1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCredit for Increasing Research Activities (R&D Tax Credit) is sponsored by Internal Revenue Service (IRS). This federal tax credit rewards businesses for increasing their research activities, providing a dollar-for-dollar reduction in federal and state tax liability.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Research credit | Internal Revenue Service Access your tax information with an IRS account.
Include Historical Content Include Historical Content Include Historical Content Include Historical Content Business and self-employed Governments and tax-exempt bonds Indian Tribal Governments Apply for an Employer ID Number (EIN) Identity Protection PIN (IP PIN) Bank Account (Direct Pay) Payment Plan (Installment Agreement) Electronic Federal Tax Payment System (EFTPS) Tax Withholding Estimator Where’s my amended return?
Businesses & Self-Employed Earned Income Credit (EITC) Clean Energy and Vehicle Credits POPULAR FORMS & INSTRUCTIONS Fake IRS email or message Businesses and self-employed Federal, state and local governments Indian tribal governments Taxpayer identification numbers (TIN) Form 6765, Credit for Increasing Research Activities About Form 6765, Credit for Increasing Research Activities IRS requests feedback on draft Instructions for Form 6765, Credit for Increasing Research Activities IRS releases revised draft Form 6765, Credit for Increasing Research Activities, following public comment IRS sets forth required information for a valid research credit claim for refund Qualified small business payroll tax credit for increasing research activities Rev.
Proc. 2025-08, Modification to change method of accounting for research or experimental expenditures under Section 174 PDF Notice 2024-12, Clarifications and Modification to Initial Interim Guidance on Amortization of Specified Research or Experimental Expenditures under Section 174 PDF Notice 2023-63, Guidance on amortization of specified research or experimental expenditures under Section 174 PDF Rev. Proc.
2023-11, Changes in accounting periods and in methods of accounting (supersedes Rev. Proc. 2023-08) Rev.
Proc 2023-08, Methods of accounting for specific research or experimental expenditures Centralized risking of research issues under IRC 41 and IRC 174 Research credit claims audit techniques guide (RCCATG): Credit for increasing research activities § 41 (revision May 2008) Revised research credit audit technique guide (revision June 2005) Audit guidelines on the application of the process of experimentation requirement for all software (revision May 2005) Research credit audit techniques guide for aerospace industry (revision January 2005) Research credit audit techniques guide for pharmaceutical industry PDF (revision April 2024) Updated interim guidance on claims for refund that include a claim for credit for increasing research activities PDF (revision December 2022) Updated guidance for allowance of the credit for increasing research activities under I.
R. C. Section 41 for taxpayers that expense research and development costs on their financial statements pursuant to ASC 730 (revision September 2020) Guidance for allowance of the credit for increasing research activities under I.
R.
C §41 for taxpayers that expense research and development costs on their financial statements pursuant to ASC 730 (revision September 2017) Guidance for computing and substantiating the credit for increasing research activities under Section 41 of the Internal Revenue Code for activities involved in developing new pharmaceutical drugs and therapeutic biologics (revision December 2012) Field directive on the use of estimates from probability samples PDF (November 2009) Amended returns/refund claims containing invalid IRC 280C(c)(3) elections (revision August 2005) Planning and examination of research credit issues in a branded pharmaceutical company (revision April 2004) Examination of legally mandated research and experimentation expenses in the biotech and pharmaceutical industries (revision October 2003) Field directive on the use of statistical and judgement sampling in research field cases PDF (revision March 2002) Page Last Reviewed or Updated: 21-May-2026
According to the current listing, eligibility includes: Businesses that incur qualifying research expenses in the U. S. Start-ups are generally businesses in operation for fewer than five years with less than $5 million in gross receipts. Confirm the full requirements in the official notice before applying.
The current listing shows generally 20% of qualified research expenditures exceeding a base amount, up to $500,000 against payroll taxes for startups. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Credit for Increasing Research Activities (R&D Tax Credit) is funded by Internal Revenue Service (IRS). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The CFC portal was decommissioned March 4, 2026. No 2026 solicitation period has been announced, no application window opened, and OPM has not said the program is over. Here's what the channel actually was and how to replace it.
Read articleCandid launched a DAF-versus-foundation grantmaking dashboard on September 21, DAFgiving360 crossed $10 billion in a single fiscal year, and the 2026 DAF Fundraising Report found median DAF revenue up 75 percent against 12 percent for everything else. For a grants-driven nonprofit, that growth is arriving through a channel a proposal cannot reach.
Read articleOn September 2, 2026, SBA published an updated commercialization benchmark: firms with more than 25 Phase II awards in five years must derive at least 33 percent of total revenue from non-SBIR sources in FY2027, and 50 percent from FY2028 onward. It takes effect November 15, 2026. Because the measurement window looks backward three completed fiscal years, the first test is already decided — and the second is two-thirds decided. Here is the arithmetic, the history, and what firms near the line should do.
Read article